Price (delayed)
$5.92
Market cap
$81.86M
P/E Ratio
12.6
Dividend/share
N/A
EPS
$0.47
Enterprise value
$85.09M
Champions Oncology is a data-driven research organization that leverages an oncology research center of excellence to develop transformative technology and accelerate oncology research and development. This technology ranges from computational-based
There are no recent dividends present for CSBR.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.